Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.

Hongwei D. Yu; Jens F. Poschet; Graham S. Timmons; Jennifer L. Taylor-Cousar; Wojciech Ornatowski; Joseph Fazio; Elizabeth Perkett; Kari R. Wilson; Hugo R. de Jonge; Vojo Deretic

Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.

Hongwei D. Yu
, Jens F. Poschet
, Graham S. Timmons
, Jennifer L. Taylor-Cousar
, Wojciech Ornatowski
, Joseph Fazio
, Elizabeth Perkett
, Kari R. Wilson
, Hugo R. de Jonge
, Vojo Deretic

Marshall University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Biochemistry and Microbiology
State	Published - Sep 1 2007

Keywords

cystic fybrosis
treatment
drug therapy
metabolism

Disciplines

Chemicals and Drugs
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Diseases
Medicine and Health Sciences
Pharmacy and Pharmaceutical Sciences
Respiratory Tract Diseases

Access to Document

http://ajplung.physiology.org/content/293/3/L712.full.pdf+html

Cite this

Yu, H. D., Poschet, J. F., Timmons, G. S., Taylor-Cousar, J. L., Ornatowski, W., Fazio, J., Perkett, E., Wilson, K. R., de Jonge, H. R., & Deretic, V. (2007). Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis. Biochemistry and Microbiology. http://ajplung.physiology.org/content/293/3/L712.full.pdf+html

Yu, HD, Poschet, JF, Timmons, GS, Taylor-Cousar, JL, Ornatowski, W, Fazio, J, Perkett, E, Wilson, KR, de Jonge, HR & Deretic, V 2007, 'Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.', Biochemistry and Microbiology. <http://ajplung.physiology.org/content/293/3/L712.full.pdf+html>

@article{bd390b80520d47d8abc57c39af4245f8,

title = "Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.",

keywords = "cystic fybrosis, treatment, drug therapy, metabolism",

author = "Yu, \{Hongwei D.\} and Poschet, \{Jens F.\} and Timmons, \{Graham S.\} and Taylor-Cousar, \{Jennifer L.\} and Wojciech Ornatowski and Joseph Fazio and Elizabeth Perkett and Wilson, \{Kari R.\} and \{de Jonge\}, \{Hugo R.\} and Vojo Deretic",

year = "2007",

month = sep,

day = "1",

language = "American English",

journal = "Biochemistry and Microbiology",

}

TY - JOUR

T1 - Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.

AU - Yu, Hongwei D.

AU - Poschet, Jens F.

AU - Timmons, Graham S.

AU - Taylor-Cousar, Jennifer L.

AU - Ornatowski, Wojciech

AU - Fazio, Joseph

AU - Perkett, Elizabeth

AU - Wilson, Kari R.

AU - de Jonge, Hugo R.

AU - Deretic, Vojo

PY - 2007/9/1

Y1 - 2007/9/1

KW - cystic fybrosis

KW - treatment

KW - drug therapy

KW - metabolism

UR - https://mds.marshall.edu/sm_bm/13

UR - http://ajplung.physiology.org/content/293/3/L712.full.pdf+html

M3 - Article

JO - Biochemistry and Microbiology

JF - Biochemistry and Microbiology

ER -

Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.

Keywords

Disciplines

Access to Document

Other files and links

Cite this